3DMed Diagnostics

Founded in Shanghai in 2010, 3DMed Diagnostics is one of the early enterprises in China engaged in precision medicine. After long-term development, 3DMed Diagnostics has adhered to global innovation as its R&D direction, and has become a precision diagnostics innovation leader rooted in China and facing the world. It has formed three major innovative business segments: "early disease diagnosis + companion diagnostics for tumors + molecular infection diagnosis". In addition, it has expanded into business segments such as medical intelligent software and pharmaceutical company cooperation, achieving multiple breakthrough results. Its products and solutions have been applied in more than 70 countries and regions in China and globally, and it has been honored with titles such as Specialized and Sophisticated "Little Giant" Enterprise, Shanghai Enterprise Technology Center, and Shanghai Science and Technology Little Giant. The group has built a comprehensive R&D platform integrating equipment engineering, electrical engineering, life science technology, materials science, and AI data analysis, with the capability of achieving fully automated operation in R&D and manufacturing in the precision diagnostics field and intelligent data processing. It has applied for and owns nearly 400 patents. The group also possesses industry-authoritative CAP/CLIA qualifications and a third-party medical laboratory accredited by China's CNAS ISO15189, covering over 70% of core top-tier hospitals in its precision diagnostics marketing network, serving more than 800 hospitals, and providing precision medicine full-process management products and services from early disease diagnosis, companion diagnostics, to dynamic disease monitoring.